TAUB REBECCA sold 3.9% of their position (18.65K shares) of MADRIGAL PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $10.30M — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+18.65K
Price / share
$15.80
Trade value
$294.67K
% of position
Common Stock
Shares
−491.00
Price / share
$547.76
Trade value
$268.95K
% of position
Common Stock
Shares
−369.00
Price / share
$548.56
Trade value
$202.42K
% of position
Common Stock
Shares
−486.00
Price / share
$550.07
Trade value
$267.33K
% of position
Common Stock
Shares
−4.72K
Price / share
$550.99
Trade value
$2.60M
% of position
Common Stock
Shares
−4.41K
Price / share
$551.85
Trade value
$2.43M
% of position
Common Stock
Shares
−3.86K
Price / share
$552.81
Trade value
$2.13M
% of position
Common Stock
Shares
−3.09K
Price / share
$553.88
Trade value
$1.71M
% of position
Common Stock
Shares
−1.03K
Price / share
$554.84
Trade value
$569.82K
% of position
Common Stock
Shares
−200.00
Price / share
$555.39
Trade value
$111.08K
% of position
Common Stock
Shares
−5.46K
Price / share
—
Trade value
—
% of position
Net shares
−5.46K
Net value
-$10M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/10/2025 | M · Option Exercise | +18.65K | $15.80 | $294.67K | 4.0% | 461.04K | 479.69K |
| Common Stock Direct | 12/10/2025 | S · Sale | −491.00 | $547.76 | $268.95K | 0.1% | 479.69K | 479.20K |
| Common Stock Direct | 12/10/2025 | S · Sale | −369.00 | $548.56 | $202.42K | 0.1% | 479.20K | 478.83K |
| Common Stock Direct | 12/10/2025 | S · Sale | −486.00 | $550.07 | $267.33K | 0.1% | 478.83K | 478.35K |
| Common Stock Direct | 12/10/2025 | S · Sale | −4.72K | $550.99 | $2.60M | 1.0% | 478.35K | 473.63K |
| Common Stock Direct | 12/10/2025 | S · Sale | −4.41K | $551.85 | $2.43M | 0.9% | 473.63K | 469.21K |
| Common Stock Direct | 12/10/2025 | S · Sale | −3.86K | $552.81 | $2.13M | 0.8% | 469.21K | 465.36K |
| Common Stock Direct | 12/10/2025 | S · Sale | −3.09K | $553.88 | $1.71M | 0.7% | 465.36K | 462.27K |
| Common Stock Direct | 12/10/2025 | S · Sale | −1.03K | $554.84 | $569.82K | 0.2% | 462.27K | 461.24K |
| Common Stock Direct | 12/10/2025 | S · Sale | −200.00 | $555.39 | $111.08K | 0.0% | 461.24K | 461.04K |
| Common Stock Direct | 12/10/2025 | G · Gift | −5.46K | — | — | 1.2% | 461.04K | 455.59K |
| Total | −5.46K | -$10M | ||||||
Stock Option (Right to Buy)
Common Stock
18.65K shares
Shares
−18.65K
Strike price
15.80
Held after
18.65K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock18.65K shares | 12/10/2025 | M · Option Exercise | −18.65K | 15.80 | — | 18.65K |
Common Stock
Indirect| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 655.54K | Indirect |
| Total | 655.54K | 655.54K indirect |